L39 Capital
  • Home
  • AI Biotech Fund
  • About
    • Performance
    • Team
  • Our Approach
    • Our Philosophy
  • Investment Process
  • Our Investments
  • Invest Now
  • Contact
Picture

Peter Rubinstein


​Peter has over 20 years of experience in early stage technology commercialisation through to ASX listings. Peter was legal counsel and new projects manager at Montech, the commercial arm of Monash University and participated in a range of businesses in diverse areas ranging from digital payments and bio- technology to sustainability and blockchain.

Peter also sits on the boards of both DigitalX Limited (ASX: DCC) and Genetic Technologies Limited (ASX: GTG).

E: [email protected]
T:  +61 415 634 468
E:  [email protected]
Level 1, Suit 7
321 Chapel Street
Prahran, Victoria, 3181
​Australia
© COPYRIGHT 2022 L39 Capital | ABN 94 614 364 117
L39 Capital Pty Ltd (L39) ABN 94 614 364 117 is a Corporate Authorised Representative (CAR #1250323) of Primary Securities Ltd (Primary) ABN 96 089 812 635 AFSL 224107. Primary is the trustee of the L39 Capital fund. L39 is authorised to provide general advice only to wholesale investors. This website is for general informational purposed only and no person(s) circumstances, objectives or needs have been taken into account when preparing this information.
  • Home
  • AI Biotech Fund
  • About
    • Performance
    • Team
  • Our Approach
    • Our Philosophy
  • Investment Process
  • Our Investments
  • Invest Now
  • Contact